Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

Nanocarrier-mediated cancer therapy: New advances in immunotherapy, chemotherapy, and radiotherapy - EurekAlert!

Study: New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications - EurekAlert!

Study identifies target for disease hyper progression after immunotherapy in kidney cancer - EurekAlert!

Hollow mesoporous carbon nanospheres derived from metal–organic frameworks for efficient sono-immunotherapy against pancreatic cancer - EurekAlert!

Colorectal cancer evades immunotherapy using a dual barrier - EurekAlert!

DNA copy-number changes help melanoma develop resistance to immunotherapy, UCLA study finds - EurekAlert!

Vitamin-engineered nanoplatforms: Revolutionizing precision oncology through immunotherapy, drug delivery, and theranostics - EurekAlert!

UCLA scientists develop one-product-fits-all immunotherapy for breast cancer - EurekAlert!

Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer - EurekAlert!

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer - EurekAlert!

Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer - EurekAlert!

mRNA-based COVID vaccines generate improved responses to immunotherapy

KEYMAKER-U03 sub-study 03A: Triplet investigational combinations of immunotherapy and targeted treatments as first-line therapy for advanced renal cell carcinoma - EurekAlert!

Myeloid immune cells may offer a new target for immunotherapy in liver cancer - EurekAlert!

Targeting "aged" immune cells: New strategy to boost immunotherapy in solid tumors - EurekAlert!

Sutter Health researchers identify promising drug combinations for immunotherapy-resistant melanoma - EurekAlert!

Tarlatamab with anti-PD-L1 as first-line maintenance after chemo-immunotherapy for ES-SCLC demonstrates acceptable safety profile and unprecedented overall survival - EurekAlert!

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC - EurekAlert!

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer - EurekAlert!

Challenging Over 150 Years of Immunotherapy: Scientists Unveil New Weapon That Kills Cancer Without the Immune System